Adam C. Ehrlich, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM) and Co-Medical Director of the Inflammatory Bowel Disease Program at LKSOM, commented on a case study regarding the drug golimumab and its presence in the circulation of a fetus whose mother has ulcerative colitis. Dr. Ehrlich, who was not part of the study, shared his thoughts with Reuters Health, and MD Alert picked up that coverage.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH